Cargando…

Global Harmonization of Pediatric Drug Development: Critical for Progress for Developing Safe and Effective Therapeutic Agents for Children

The article, "Questionable Industry-Sponsored Studies in Children and Adolescents in Slovenia" provides an opportunity to discuss evolving US and EU legislative measures to improve the available clinical trial-derived pediatric data and provide coherent labeling for pediatric providers in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mulberg, Andrew E., Cripps, Timothy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677566/ https://www.ncbi.nlm.nih.gov/pubmed/31388364 http://dx.doi.org/10.1016/j.curtheres.2019.01.006

Ejemplares similares

Global Pediatric Drug Development
por: Thomsen, Mette Due Theilade
Publicado: (2019)

A spatially-explicit harmonized global dataset of critical infrastructure
por: Nirandjan, Sadhana, et al.
Publicado: (2022)

Safe development of nanotechnology: A global challenge
por: Madhwani, Kishore P
Publicado: (2013)

Antihypertensive agents: a long way to safe drug prescribing in children
por: Siddiqi, Nida, et al.
Publicado: (2019)

Data silos are undermining drug development and failing rare disease patients
por: Denton, Nathan, et al.
Publicado: (2021)

SafeScrum - agile development of safety-critical software
por: Hanssen, Geir Kjetil, et al.
Publicado: (2018)

A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies
por: Kumari, Monika, et al.
Publicado: (2022)

Some New Developments For Harmon
por: Keil, Eberhard
Publicado: (1981)

Discovery and development of safe-in-man broad-spectrum antiviral agents
por: Andersen, Petter I., et al.
Publicado: (2020)

Measuring Antimicrobial Use Needs Global Harmonization
por: Umair, Muhammad, et al.
Publicado: (2021)

Recent advances on drug development and emerging therapeutic agents for Alzheimer’s disease
por: Athar, Teeba, et al.
Publicado: (2021)

Amendment to Some New Developments For Harmon
por: Keil, Eberhard
Publicado: (1981)

Why It Is Important to Develop an Effective and Safe Pediatric COVID-19 Vaccine
por: Principi, Nicola, et al.
Publicado: (2021)

Global Cancer Drug Development—A Report From the 2022 Accelerating Anticancer Agent Development and Validation Meeting
por: Wilson, Brooke E., et al.
Publicado: (2023)

Peripheral Inotropes in Critically Ill Children: Is It Safe?
por: Mooli, Ravi K., et al.
Publicado: (2021)

Promoting the development of novel therapeutic agents
por: Dixon, Dennis M.
Publicado: (2021)

Discovery and Development of Anti-HIV Therapeutic Agents: Progress Towards Improved HIV Medication
por: Maeda, Kenji, et al.
Publicado: (2019)

Drug–drug interaction database for safe prescribing of systemic antifungal agents
por: Niazi-Ali, Saarah, et al.
Publicado: (2021)

Ensuring continued progress for development of COVID-19 therapeutics in children
por: Noel, Gary J., et al.
Publicado: (2021)

Pediatric Clinical Research Networks: Role in Accelerating Development of Therapeutics in Children
por: Greenberg, Rachel G., et al.
Publicado: (2022)

Development of Harmonized COVID-19 Occupational Questionnaires
por: Schlünssen, Vivi, et al.
Publicado: (2022)

Advancing Pediatric Antibacterial Drug Development: A Critical Need to Reinvent our Approach
por: Noel, Gary J, et al.
Publicado: (2018)

Global Regulatory and Public Health Initiatives to Advance Pediatric Drug Development for Rare Diseases
por: Epps, Carla, et al.
Publicado: (2022)

Pediatric Melanoma and Drug Development
por: Rose, Klaus, et al.
Publicado: (2018)

The Challenges of Pediatric Drug Development
por: Rose, Klaus
Publicado: (2019)

A recent development of new therapeutic agents and novel drug targets for cancer treatment
por: Kifle, Zemene Demelash, et al.
Publicado: (2021)

Current progress and future perspectives in the development of anti-polo-like kinase 1 therapeutic agents
por: Park, Jung-Eun, et al.
Publicado: (2017)

Development of Class IIa Bacteriocins as Therapeutic Agents
por: Lohans, Christopher T., et al.
Publicado: (2012)

The Development of Toad Toxins as Potential Therapeutic Agents
por: Qi, Ji, et al.
Publicado: (2018)

Clinical development of photodynamic agents and therapeutic applications
por: Baskaran, Rengarajan, et al.
Publicado: (2018)

Ensuring the quality of medicines in India: An update on the development, modernization, and harmonization of drug standards in the Indian Pharmacopoeia
por: Jadaun, Gaurav Pratap Singh, et al.
Publicado: (2023)

Global progress towards early childhood development for children with disabilities, 2013–2023
por: Olusanya, Bolajoko O, et al.
Publicado: (2023)

Food and drug administration’s critical path initiative and innovations in drug development paradigm: Challenges, progress, and controversies
por: Mahajan, Rajiv, et al.
Publicado: (2010)

The location of critical points of analytic and harmonic functions
por: Walsh, J L
Publicado: (1950)

Global pharmacovigilance regulations: Call for re-harmonization
por: Singh, Ajay, et al.
Publicado: (2018)

Workshop Report on Global Harmonization of Enterovirus Vaccines
por: Weng, Tzu-Yu, et al.
Publicado: (2020)

Global Harmonization of Urbanization Measures: Proceed with Care
por: Balk, Deborah, et al.
Publicado: (2021)

Development of a safe drug administration assessment instrument for nursing students
por: Cancino, Karen Domínguez, et al.
Publicado: (2020)

Fragment- and structure-based drug discovery for developing therapeutic agents targeting the DNA Damage Response
por: Wilson, David M., et al.
Publicado: (2020)

Progress Toward Development of Effective and Safe African Swine Fever Virus Vaccines
por: Sang, Huldah, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_krvhhfnqk4fhfd2j1de4umbihj